# Vinorelbine in Treating Children With Recurrent or Refractory Cancers

> **NCT00003234** · PHASE2 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 50 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors
- Neuroblastoma
- Sarcoma

## Interventions

- **DRUG:** vinorelbine tartrate

## Key facts

- **NCT ID:** NCT00003234
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-05
- **Primary completion:** 2006-03
- **Final completion:** 2007-03
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003234, "Vinorelbine in Treating Children With Recurrent or Refractory Cancers". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00003234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*